Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Current Gene Therapy

Role of Exosomal miRNAs and Epigenetic Modifications in Diabetic Nephropathy: Insights into Novel Diagnostic and Therapeutic Strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

SNSrinivas NagaramASAniruddha SenVSVijay Singh

Discussion

Loading...

Member takes

Overview

This review examines exosomal miRNAs and epigenetic modifications in diabetic nephropathy, suggesting potential diagnostic and therapeutic strategies.

Key Points

  • Exosomal miRNAs serve as promising early biomarkers for diabetic nephropathy, aiding in disease identification and monitoring.
  • Significant epigenetic modifications, including DNA methylation and histone alteration, play a critical role in diabetic nephropathy progression.
  • The interplay between exosomal miRNAs and epigenetic changes influences inflammatory pathways, such as IL-6 and NF-κB.
  • Improved detection techniques for miRNAs and exosomal isolation are essential for clinical translation and effective patient management.

Cite This Study

Nagaram et al. (2025) studied this question.

synapsesocial.com/papers/68bb49c46d6d5674bccffa07https://doi.org/10.2174/0115665232376803250815065514
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in the Epigenetic Mechanisms of Diabetic Nephropathy Pathogenesis2025 · 11 citations
  2. 2Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy2025 · 6 citations
  3. 3Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy2020 · 44 citations
  4. 4The Role of Non-Coding RNAs in the Pathogenesis and Progression of Diabetic Kidney Disease2026 · 2 citations
  5. 5Clinical Importance of miRNA in Diabetic Neuropathy: Pathophysiology, Diagnosis, and Therapeutic Potential2025 · 1 citations